Clinical Evidence

Evom AI's Proven Impact in Cardiology

3
Congress abstracts
0
Peer-reviewed publications
Congress Abstracts

Published Studies

Our scientific evidence covers echo automation and EKG-based predictions.

Echo AI EACVI 2026

Development and validation of AI algorithm for automated regional wall motion abnormality assessment and coronary artery disease prediction

A deep learning model using temporal shift module architecture, trained on 22,527 echo studies and validated across 115 patients (1,955 segments), achieved expert-comparable performance for RWMA detection and significant CAD prediction — supporting AI as an automated screening tool for wall motion analysis.

Secondary hospital · Incheon, Korea · n = 115 patients Read study
Echo AI EACVI 2026

AI-Based Automated Echocardiographic Analysis: Validation Against Manual Echocardiography and CMR in Ischemic, Hypertrophic, and Amyloid Cardiomyopathies

Single-center retrospective study across 145 patients with ICM, HCM, and cardiac amyloidosis demonstrating that AI-Echo measurements match expert manual echocardiography and show comparable or superior agreement with CMR for volumetric and functional parameters.

Single tertiary center · ICM, HCM, Cardiac Amyloidosis · n = 145 patients Read study
EKG AI EACVI 2026

Development and Multicenter Validation of an Echocardiography-Supervised AI Electrocardiogram Model for Left-Chamber Abnormality Detection

Multicenter study across 205,916 ECG–echo pairs and four validation cohorts (hospital, primary care, health screening) demonstrating robust simultaneous detection of LVH, LAE, and LVE — outperforming conventional rule-based ECG criteria across all settings (all p<0.001).

Multicenter · 205,916 ECG–echo pairs · 4 validation cohorts Read study